Sixteen cases of focal nodular hyperplasia (FNH) of the liver were followed by ultrasound (US) for a mean of 33 months (range 6-81). In 69% of the cases, the diagnosis was incidental. On US the lesions were single in 75% of the cases, localized in the right lobe in 75%, and subcapsular in 50%. No sp
Focal nodular hyperplasia of the liver
β Scribed by John E. Evans; Robert Dick; Prof. Sheila Sherlock
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 323 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 48-year-old woman is described with a pancreatic islet cell carcinoma that had no clinical evidence of hormone production. This neoplasm was removed by radical distal pancreatectomy . Immunohistochemical and extraction studies performed on the tumor tissue revealed that it was producing serotonin
Focal nodular hyperplasia (FNH) of the liver is a benign tumor commonly considered as a reactive disorder related to a pre-existing vascular malformation. However, the pathogenesis of this lesion has been recently discussed. To determine whether FNH is a polyclonal or a clonal lesion, we investigate
We read with interest the paper by Fabre et al.1 We agree with their major remark that the absence of radiologic criteria for focal nodular hyperplasia (FNH) does not preclude a positive diagnosis of liver needle biopsy as seen in 11 of 24 cases of group 111 (showing 2 or fewer
Focal nodular hyperplasia (FNH) has been well characterized in native livers, but to our knowledge, no cases of FNH have been described in liver allografts. We review the clinicopathological features of 6 FNHs identified in 4 patients after orthotopic liver transplantation. There were 3 male patient